- Home
- SLQT vs ORIC Comparison
SLQT vs ORIC Comparison
Compare SLQT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLQT | ORIC |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.6M | 1.3B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SLQT | ORIC |
|---|---|---|
| Price | $0.62 | $12.12 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | $2.88 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 1.4M | 1.3M |
| Earning Date | 05-11-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 105.00 | 19.67 |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,526,594,000.00 | N/A |
| Revenue This Year | $11.42 | N/A |
| Revenue Next Year | $7.76 | N/A |
| P/E Ratio | $59.37 | ★ N/A |
| Revenue Growth | ★ 15.50 | N/A |
| 52 Week Low | $0.58 | $3.90 |
| 52 Week High | $3.73 | $14.93 |
Technical Indicators
Market Signals| Indicator | SLQT | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 32.74 | 52.44 |
| Support Level | N/A | $11.74 |
| Resistance Level | $0.94 | $12.60 |
| Average True Range (ATR) | 0.05 | 0.80 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 27.76 | 68.09 |
Price Performance
Historical ComparisonAbout SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.